Trodelvy
Term · Oncology and biomedicine · MLC-T-ONC-008922
A drug used to treat adults with certain types of breast cancer that have already been treated with other therapy. It is also being studied in the treatment of other types of cancer. Trodelvy contains a monoclonal antibody called sacituzumab that binds to a protein called TROP2, which is found on some cancer cells. It also contains an anticancer drug called SN-38, which may help kill cancer cells. Trodelvy is a type of antibody-drug conjugate. Also called sacituzumab govitecan.
| Identifier | MLC-T-ONC-008922 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | sacituzumab govitecan |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-008922",
"term": "Trodelvy",
"field": "Oncology and biomedicine",
"definition": "A drug used to treat adults with certain types of breast cancer that have already been treated with other therapy. It is also being studied in the treatment of other types of cancer. Trodelvy contains a monoclonal antibody called sacituzumab that binds to a protein called TROP2, which is found on some cancer cells. It also contains an anticancer drug called SN-38, which may help kill cancer cells. Trodelvy is a type of antibody-drug conjugate. Also called sacituzumab govitecan.",
"synonyms": [
"sacituzumab govitecan"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/trodelvy/"
}
Record 16,753 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.